Relationship between menopausal hormone therapy and incidence of fractures in postmenopausal women
CONCLUSION: In menopausal women, all MHT including conventional-dose EPT, ET and tibolone tended to lower the incidence of fractures. The effects, however, varied with the type of fracture and type of MHT.PMID:37947171 | DOI:10.1080/13697137.2023.2273528 (Source: Climacteric)
Source: Climacteric - November 10, 2023 Category: Geriatrics Authors: H Kim M J Kang J K Baek J K Lee E A Choi B H Yun E H Kim S K Seo Source Type: research
Relationship between menopausal hormone therapy and incidence of fractures in postmenopausal women
CONCLUSION: In menopausal women, all MHT including conventional-dose EPT, ET and tibolone tended to lower the incidence of fractures. The effects, however, varied with the type of fracture and type of MHT.PMID:37947171 | DOI:10.1080/13697137.2023.2273528 (Source: Climacteric)
Source: Climacteric - November 10, 2023 Category: Geriatrics Authors: H Kim M J Kang J K Baek J K Lee E A Choi B H Yun E H Kim S K Seo Source Type: research
Relationship between menopausal hormone therapy and incidence of fractures in postmenopausal women
CONCLUSION: In menopausal women, all MHT including conventional-dose EPT, ET and tibolone tended to lower the incidence of fractures. The effects, however, varied with the type of fracture and type of MHT.PMID:37947171 | DOI:10.1080/13697137.2023.2273528 (Source: Climacteric)
Source: Climacteric - November 10, 2023 Category: Geriatrics Authors: H Kim M J Kang J K Baek J K Lee E A Choi B H Yun E H Kim S K Seo Source Type: research
Relationship between menopausal hormone therapy and incidence of fractures in postmenopausal women
CONCLUSION: In menopausal women, all MHT including conventional-dose EPT, ET and tibolone tended to lower the incidence of fractures. The effects, however, varied with the type of fracture and type of MHT.PMID:37947171 | DOI:10.1080/13697137.2023.2273528 (Source: Climacteric)
Source: Climacteric - November 10, 2023 Category: Geriatrics Authors: H Kim M J Kang J K Baek J K Lee E A Choi B H Yun E H Kim S K Seo Source Type: research
Relationship between menopausal hormone therapy and incidence of fractures in postmenopausal women
CONCLUSION: In menopausal women, all MHT including conventional-dose EPT, ET and tibolone tended to lower the incidence of fractures. The effects, however, varied with the type of fracture and type of MHT.PMID:37947171 | DOI:10.1080/13697137.2023.2273528 (Source: Climacteric)
Source: Climacteric - November 10, 2023 Category: Geriatrics Authors: H Kim M J Kang J K Baek J K Lee E A Choi B H Yun E H Kim S K Seo Source Type: research
Relationship between menopausal hormone therapy and incidence of fractures in postmenopausal women
CONCLUSION: In menopausal women, all MHT including conventional-dose EPT, ET and tibolone tended to lower the incidence of fractures. The effects, however, varied with the type of fracture and type of MHT.PMID:37947171 | DOI:10.1080/13697137.2023.2273528 (Source: Climacteric)
Source: Climacteric - November 10, 2023 Category: Geriatrics Authors: H Kim M J Kang J K Baek J K Lee E A Choi B H Yun E H Kim S K Seo Source Type: research
Relationship between menopausal hormone therapy and incidence of fractures in postmenopausal women
CONCLUSION: In menopausal women, all MHT including conventional-dose EPT, ET and tibolone tended to lower the incidence of fractures. The effects, however, varied with the type of fracture and type of MHT.PMID:37947171 | DOI:10.1080/13697137.2023.2273528 (Source: Climacteric)
Source: Climacteric - November 10, 2023 Category: Geriatrics Authors: H Kim M J Kang J K Baek J K Lee E A Choi B H Yun E H Kim S K Seo Source Type: research
Relationship between menopausal hormone therapy and incidence of fractures in postmenopausal women
CONCLUSION: In menopausal women, all MHT including conventional-dose EPT, ET and tibolone tended to lower the incidence of fractures. The effects, however, varied with the type of fracture and type of MHT.PMID:37947171 | DOI:10.1080/13697137.2023.2273528 (Source: Climacteric)
Source: Climacteric - November 10, 2023 Category: Geriatrics Authors: H Kim M J Kang J K Baek J K Lee E A Choi B H Yun E H Kim S K Seo Source Type: research
Changes in menopausal symptoms comparing oral estradiol versus transdermal estradiol
CONCLUSIONS: This study shows that both transdermal and oral estradiol are effective in relieving menopausal symptoms, with little difference in treatment efficacy and safety.CLINICAL TRIAL NUMBER: ChiCTR2300073146.PMID:37942806 | DOI:10.1080/13697137.2023.2273530 (Source: Climacteric)
Source: Climacteric - November 9, 2023 Category: Geriatrics Authors: R Tang Z Xie X Ruan Z Zhang M Ren J Wu K Shu H Shi M Xie S Lv X Yang R Chen Q Yu Source Type: research
Use of MHT in women with cardiovascular disease: a systematic review and meta-analysis
This study confirms no benefit of MHT for secondary CVD prevention, highlighting evidence limitations and the importance of shared decision-making when managing menopausal symptoms in women with CVD.PMID:37933495 | DOI:10.1080/13697137.2023.2273524 (Source: Climacteric)
Source: Climacteric - November 7, 2023 Category: Geriatrics Authors: S Bontempo L Yeganeh R Giri A J Vincent Source Type: research
Use of MHT in women with cardiovascular disease: a systematic review and meta-analysis
This study confirms no benefit of MHT for secondary CVD prevention, highlighting evidence limitations and the importance of shared decision-making when managing menopausal symptoms in women with CVD.PMID:37933495 | DOI:10.1080/13697137.2023.2273524 (Source: Climacteric)
Source: Climacteric - November 7, 2023 Category: Geriatrics Authors: S Bontempo L Yeganeh R Giri A J Vincent Source Type: research
Use of MHT in women with cardiovascular disease: a systematic review and meta-analysis
This study confirms no benefit of MHT for secondary CVD prevention, highlighting evidence limitations and the importance of shared decision-making when managing menopausal symptoms in women with CVD.PMID:37933495 | DOI:10.1080/13697137.2023.2273524 (Source: Climacteric)
Source: Climacteric - November 7, 2023 Category: Geriatrics Authors: S Bontempo L Yeganeh R Giri A J Vincent Source Type: research
Cardiovascular risk assessment in women: which women are suited for menopausal hormone therapy?
Climacteric. 2023 Nov 6:1-4. doi: 10.1080/13697137.2023.2259799. Online ahead of print.ABSTRACTIndividual risk assessment for atherosclerotic cardiovascular disease is important for safe menopausal hormone prescription. Besides the traditional risk factors, female-specific risk variables related to pregnancy and gynecologic conditions importantly contribute to a more tailored risk assessment in women at middle age. Of these, prior pre-eclampsia/HELLP (hemolysis, elevated liver enzymes and low platelets) syndrome and early spontaneous menopause (<40 years) seem to be the strongest adverse risk variables. Concomitant infl...
Source: Climacteric - November 6, 2023 Category: Geriatrics Authors: A H E M Maas Source Type: research
Menopausal age and cardiovascular disease risk in American women: evidence from the National Health and Nutrition Examination Survey
CONCLUSION: Menopausal age is associated with the risk of developing CVD in American females. Specifically, if menopause occurs earlier, there is an increased risk of CVD. Additionally, early-onset CVD significantly raises the risk of premature menopause, which in turn has important implications for female reproductive health.PMID:37921228 | DOI:10.1080/13697137.2023.2273526 (Source: Climacteric)
Source: Climacteric - November 3, 2023 Category: Geriatrics Authors: Z Zhang Y Hu X Cui M Lu M Zhang C Li Source Type: research
Menopausal age and cardiovascular disease risk in American women: evidence from the National Health and Nutrition Examination Survey
CONCLUSION: Menopausal age is associated with the risk of developing CVD in American females. Specifically, if menopause occurs earlier, there is an increased risk of CVD. Additionally, early-onset CVD significantly raises the risk of premature menopause, which in turn has important implications for female reproductive health.PMID:37921228 | DOI:10.1080/13697137.2023.2273526 (Source: Climacteric)
Source: Climacteric - November 3, 2023 Category: Geriatrics Authors: Z Zhang Y Hu X Cui M Lu M Zhang C Li Source Type: research
